World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

AYURVEDIC MANAGEMANT OF VICHARCHIKA W.S.R. ECZEMA: A CASE STUDY

*Dr. Shraddha Joge, Dr. Sharad Joge, Dr. Madhava Diggavi

ABSTRACT

Vicharchika, classified under K?hudra Kushtha in Ayurveda, closely parallels eczema described in modern dermatology. Eczema is a chronic, relapsing inflammatory skin disorder provoked by diverse stimuli such as toxic chemical injury, mechanical trauma, and immunological reactions, with significant global prevalence, especially among children. Eczema affects about 15–20% of children and 2–10% of adults worldwide. In India, prevalence ranges from 3–7% in children and 1–9% overall. Methodology: A prospective, randomized, open-labelled clinical experimental study. A 68-year-old male patient presented with thick, rough, blackish lesions over the bilateral ankle joints, cracks over the plantar region, Strava, Kandu, and Daha for 4 years. The Ayurvedic diagnosis was made as Vicharchika based on classical signs and symptoms. The patient was treated with Snehapana using Mahatiktaka Ghrita 30 ml (test dose), followed by 50, 70, 90, and 110 ml. Vishrama Kala for 3 days consisted of Sarvanga Abhyanga with Ksheerabala Taila followed by Nadi Sweda. Virechana was administered with Trivritta Avaleha, followed by Siravyadha and Prakshalana with Panchavalkala Kwatha, after which Gandhakadhya Malahara was applied. Oral medications included Arogyavardhini Vati 2 tabs BD, Gandhaka Rasayana 1 tab BD, Aragwadadhi Kashaya 15 ml BD, Pancha Nimba Churna ½ tsp BD before food, and Panchatikta Guggulu Ghrita 10 ml BD. Result: The treatment showed significant improvement in the EASI score—from 23.20 (severe) to 6.2 (mild). Marked improvement was observed in subjective parameters with reduced Kandu, Strava, Rukshata, Shyava Varnata, etc. Conclusion: Despite major advances in dermatology, contemporary medicine lacks a definitive curative therapy for eczema. Ayurveda offers a rational and biologically coherent framework for managing chronic inflammatory dermatoses such as eczema. Its emphasis on systemic purification, metabolic correction, and tissue-level restoration provides a complementary approach to modern dermatologic care.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR